Literature DB >> 16516335

Mucosal delivery of vaccine antigens and its advantages in pediatrics.

Maria Teresa De Magistris1.   

Abstract

The delivery of vaccines through the mucosal route is very practical, non-invasive and efficacious for the induction of mucosal and systemic immune responses. Appropriately formulated mucosal vaccines can stimulate all arms of the immune system and could be exploited for protection against pathogens that infect the host through the mucosal surfaces as well as those acquired through other routes. There are few available mucosal vaccines so far and these are mainly based on whole microorganisms. The development of new generation mucosal vaccines based on purified protective antigens has been hampered for a long time by the low immunogenicity of soluble antigens and by the lack of safe and efficacious mucosal adjuvants. However, we have now several promising candidate adjuvants and delivery systems for mucosal immunization. In this review I will illustrate the advantages of mucosal vaccination and I will discuss what we still need to develop safe and efficacious mucosal vaccines that would be beneficial especially for young children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516335     DOI: 10.1016/j.addr.2006.01.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  26 in total

Review 1.  Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.

Authors:  Vikram Virdi; Paloma Juarez; Veronique Boudolf; Ann Depicker
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

2.  Pollen grains for oral vaccination.

Authors:  Shashwati U Atwe; Yunzhe Ma; Harvinder Singh Gill
Journal:  J Control Release       Date:  2014-08-23       Impact factor: 9.776

3.  Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels.

Authors:  Marloes Vissers; Inge M L Ahout; Marien I de Jonge; Gerben Ferwerda
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

4.  A single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock.

Authors:  Satoshi Yamasaki; Yoshiaki Miura; Julia Davydova; Selwyn M Vickers; Masato Yamamoto
Journal:  Clin Vaccine Immunol       Date:  2013-07-24

5.  Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?

Authors:  Bozena Dziadek; Anna Brzostek
Journal:  Bioengineered       Date:  2012-08-15       Impact factor: 3.269

6.  Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.

Authors:  Filippo Veglia; Ester Sciaraffia; Antonella Riccomi; Dora Pinto; Donatella R M Negri; Maria Teresa De Magistris; Silvia Vendetti
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

7.  Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.

Authors:  Tarek Hamouda; Joyce A Sutcliffe; Susan Ciotti; James R Baker
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

8.  Intranasal bacteria induce Th1 but not Treg or Th2.

Authors:  M Costalonga; P P Cleary; L A Fischer; Z Zhao
Journal:  Mucosal Immunol       Date:  2008-10-08       Impact factor: 7.313

Review 9.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

10.  Probiotics and gastrointestinal disease: successes, problems and future prospects.

Authors:  Eamonn P Culligan; Colin Hill; Roy D Sleator
Journal:  Gut Pathog       Date:  2009-11-23       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.